Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2026-01-09 @ 12:03 AM
Study NCT ID:
NCT03557333
Status:
COMPLETED
Last Update Posted:
2021-03-11
First Post:
2018-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301)
Sponsor:
Impel Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
INP104-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None